annual EBIT:
-$156.54M+$372.07M(+70.39%)Summary
- As of today (May 21, 2025), NVAX annual earnings before interest & taxes is -$156.54 million, with the most recent change of +$372.07 million (+70.39%) on December 31, 2024.
- During the last 3 years, NVAX annual EBIT has risen by +$1.54 billion (+90.76%).
- NVAX annual EBIT is now -3526.97% below its all-time high of -$4.32 million, reached on December 31, 2005.
Performance
NVAX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$525.57M+$591.57M(+896.36%)Summary
- As of today (May 21, 2025), NVAX quarterly earnings before interest & taxes is $525.57 million, with the most recent change of +$591.57 million (+896.36%) on March 31, 2025.
- Over the past year, NVAX quarterly EBIT has increased by +$666.75 million (+472.28%).
- NVAX quarterly EBIT is now at all-time high.
Performance
NVAX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$510.21M+$666.75M(+425.93%)Summary
- As of today (May 21, 2025), NVAX TTM earnings before interest & taxes is $510.21 million, with the most recent change of +$666.75 million (+425.93%) on March 31, 2025.
- Over the past year, NVAX TTM EBIT has increased by +$891.59 million (+233.78%).
- NVAX TTM EBIT is now at all-time high.
Performance
NVAX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NVAX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +70.4% | +472.3% | +233.8% |
| 3 y3 years | +90.8% | +149.2% | +140.3% |
| 5 y5 years | -29.9% | +2403.4% | +594.6% |
NVAX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +90.8% | at high | +204.5% | at high | +135.7% |
| 5 y | 5-year | -29.9% | +90.8% | at high | +163.7% | at high | +130.1% |
| alltime | all time | -3527.0% | +90.8% | at high | +163.7% | at high | +130.1% |
NVAX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $525.57M(-896.4%) | $510.21M(-425.9%) |
| Dec 2024 | -$156.54M(-70.4%) | -$66.00M(-44.1%) | -$156.54M(-40.5%) |
| Sep 2024 | - | -$118.10M(-170.0%) | -$263.13M(-3.8%) |
| Jun 2024 | - | $168.73M(-219.5%) | -$273.65M(-28.2%) |
| Mar 2024 | - | -$141.18M(-18.2%) | -$381.39M(-27.9%) |
| Dec 2023 | -$528.62M(-16.6%) | -$172.58M(+34.2%) | -$528.62M(-1.4%) |
| Sep 2023 | - | -$128.61M(-310.9%) | -$535.94M(-5.9%) |
| Jun 2023 | - | $60.99M(-121.1%) | -$569.30M(-49.8%) |
| Mar 2023 | - | -$288.41M(+60.3%) | -$1.13B(+78.8%) |
| Dec 2022 | -$633.77M(-62.6%) | -$179.91M(+11.1%) | -$633.77M(-50.4%) |
| Sep 2022 | - | -$161.97M(-67.8%) | -$1.28B(-10.5%) |
| Jun 2022 | - | -$502.83M(-338.4%) | -$1.43B(+12.6%) |
| Mar 2022 | - | $210.95M(-125.6%) | -$1.27B(-25.2%) |
| Dec 2021 | -$1.69B(+320.1%) | -$824.54M(+164.9%) | -$1.69B(+62.4%) |
| Sep 2021 | - | -$311.21M(-9.2%) | -$1.04B(+12.8%) |
| Jun 2021 | - | -$342.80M(+59.3%) | -$924.55M(+55.1%) |
| Mar 2021 | - | -$215.22M(+23.9%) | -$596.23M(+47.6%) |
| Dec 2020 | -$403.11M(+234.5%) | -$173.69M(-9.9%) | -$403.83M(+56.0%) |
| Sep 2020 | - | -$192.85M(+1232.4%) | -$258.92M(+219.4%) |
| Jun 2020 | - | -$14.47M(-36.6%) | -$81.07M(-21.4%) |
| Mar 2020 | - | -$22.82M(-20.7%) | -$103.15M(-14.4%) |
| Dec 2019 | -$120.51M(-30.2%) | -$28.78M(+91.9%) | -$120.51M(-12.7%) |
| Sep 2019 | - | -$15.00M(-59.0%) | -$138.01M(-16.1%) |
| Jun 2019 | - | -$36.56M(-9.0%) | -$164.54M(-2.9%) |
| Mar 2019 | - | -$40.17M(-13.2%) | -$169.43M(-1.8%) |
| Dec 2018 | -$172.56M(+1.7%) | -$46.29M(+11.5%) | -$172.56M(-0.6%) |
| Sep 2018 | - | -$41.52M(+0.2%) | -$173.59M(+0.3%) |
| Jun 2018 | - | -$41.45M(-4.3%) | -$173.16M(+0.3%) |
| Mar 2018 | - | -$43.30M(-8.5%) | -$172.66M(+1.7%) |
| Dec 2017 | -$169.70M(-36.4%) | -$47.32M(+15.2%) | -$169.70M(-3.6%) |
| Sep 2017 | - | -$41.09M(+0.3%) | -$175.98M(-11.0%) |
| Jun 2017 | - | -$40.95M(+1.5%) | -$197.63M(-15.0%) |
| Mar 2017 | - | -$40.34M(-24.7%) | -$232.52M(-12.9%) |
| Dec 2016 | -$267.00M(+70.4%) | -$53.60M(-14.6%) | -$267.00M(-8.6%) |
| Sep 2016 | - | -$62.74M(-17.3%) | -$292.10M(+11.3%) |
| Jun 2016 | - | -$75.84M(+1.4%) | -$262.41M(+26.7%) |
| Mar 2016 | - | -$74.82M(-4.9%) | -$207.18M(+32.2%) |
| Dec 2015 | -$156.70M(+89.3%) | -$78.69M(+138.1%) | -$156.70M(+43.0%) |
| Sep 2015 | - | -$33.06M(+60.3%) | -$109.54M(+13.9%) |
| Jun 2015 | - | -$20.61M(-15.3%) | -$96.17M(+3.0%) |
| Mar 2015 | - | -$24.33M(-22.8%) | -$93.37M(+12.8%) |
| Dec 2014 | -$82.79M(+59.8%) | -$31.54M(+60.3%) | -$82.79M(+26.8%) |
| Sep 2014 | - | -$19.68M(+10.5%) | -$65.27M(+7.3%) |
| Jun 2014 | - | -$17.81M(+29.5%) | -$60.83M(+9.4%) |
| Mar 2014 | - | -$13.76M(-1.9%) | -$55.60M(+7.3%) |
| Dec 2013 | -$51.80M(+81.9%) | -$14.02M(-8.0%) | -$51.80M(+13.1%) |
| Sep 2013 | - | -$15.24M(+21.1%) | -$45.79M(+21.2%) |
| Jun 2013 | - | -$12.58M(+26.4%) | -$37.77M(+21.4%) |
| Mar 2013 | - | -$9.96M(+24.2%) | -$31.10M(+9.2%) |
| Dec 2012 | -$28.48M(+50.3%) | -$8.02M(+11.1%) | -$28.48M(+17.8%) |
| Sep 2012 | - | -$7.21M(+21.9%) | -$24.16M(+19.8%) |
| Jun 2012 | - | -$5.92M(-19.3%) | -$20.16M(+7.1%) |
| Mar 2012 | - | -$7.33M(+98.1%) | -$18.82M(-0.6%) |
| Dec 2011 | -$18.94M(-47.6%) | -$3.70M(+15.3%) | -$18.94M(-13.3%) |
| Sep 2011 | - | -$3.21M(-29.9%) | -$21.84M(-24.7%) |
| Jun 2011 | - | -$4.58M(-38.5%) | -$28.98M(-12.9%) |
| Mar 2011 | - | -$7.45M(+13.0%) | -$33.26M(-10.7%) |
| Dec 2010 | -$36.15M | -$6.60M(-36.3%) | -$37.26M(-20.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | -$10.36M(+17.0%) | -$47.00M(+4.7%) |
| Jun 2010 | - | -$8.86M(-22.7%) | -$44.90M(+2.3%) |
| Mar 2010 | - | -$11.45M(-29.9%) | -$43.88M(+10.9%) |
| Dec 2009 | -$39.56M(+15.1%) | -$16.33M(+97.7%) | -$39.56M(+22.0%) |
| Sep 2009 | - | -$8.26M(+5.5%) | -$32.44M(-4.3%) |
| Jun 2009 | - | -$7.83M(+9.7%) | -$33.90M(-1.1%) |
| Mar 2009 | - | -$7.14M(-22.5%) | -$34.28M(-0.2%) |
| Dec 2008 | -$34.36M(+13.5%) | -$9.21M(-5.3%) | -$34.36M(+20.8%) |
| Sep 2008 | - | -$9.73M(+18.6%) | -$28.45M(+1.7%) |
| Jun 2008 | - | -$8.20M(+13.6%) | -$27.98M(-1.8%) |
| Mar 2008 | - | -$7.22M(+119.1%) | -$28.50M(-2.1%) |
| Dec 2007 | -$30.27M(+43.4%) | -$3.30M(-64.4%) | -$29.12M(-0.2%) |
| Sep 2007 | - | -$9.26M(+6.1%) | -$29.17M(+13.9%) |
| Jun 2007 | - | -$8.72M(+11.3%) | -$25.61M(+7.1%) |
| Mar 2007 | - | -$7.84M(+134.1%) | -$23.92M(+13.3%) |
| Dec 2006 | -$21.12M(+389.2%) | -$3.35M(-41.2%) | -$21.12M(+240.4%) |
| Sep 2006 | - | -$5.69M(-19.1%) | -$6.20M(+125.8%) |
| Jun 2006 | - | -$7.04M(+39.8%) | -$2.75M(+194.1%) |
| Mar 2006 | - | -$5.04M(-143.5%) | -$934.00K(-78.4%) |
| Dec 2005 | -$4.32M(-82.4%) | $11.56M(-616.9%) | -$4.32M(-83.3%) |
| Sep 2005 | - | -$2.24M(-57.2%) | -$25.79M(-0.3%) |
| Jun 2005 | - | -$5.22M(-37.9%) | -$25.87M(-7.6%) |
| Mar 2005 | - | -$8.42M(-15.0%) | -$27.98M(+14.4%) |
| Dec 2004 | -$24.46M(+52.4%) | -$9.91M(+327.1%) | -$24.46M(+38.9%) |
| Sep 2004 | - | -$2.32M(-68.4%) | -$17.62M(-3.5%) |
| Jun 2004 | - | -$7.34M(+49.9%) | -$18.26M(+17.4%) |
| Mar 2004 | - | -$4.90M(+60.0%) | -$15.55M(-3.1%) |
| Dec 2003 | -$16.05M(-25.5%) | -$3.06M(+3.4%) | -$16.05M(-6.0%) |
| Sep 2003 | - | -$2.96M(-36.1%) | -$17.09M(-17.1%) |
| Jun 2003 | - | -$4.63M(-14.2%) | -$20.60M(-4.1%) |
| Mar 2003 | - | -$5.40M(+32.0%) | -$21.49M(-0.3%) |
| Dec 2002 | -$21.56M(+132.9%) | -$4.09M(-36.8%) | -$21.56M(+5.1%) |
| Sep 2002 | - | -$6.48M(+17.5%) | -$20.52M(+25.0%) |
| Jun 2002 | - | -$5.51M(+0.7%) | -$16.41M(+30.5%) |
| Mar 2002 | - | -$5.47M(+79.6%) | -$12.58M(+35.9%) |
| Dec 2001 | -$9.26M(-27.4%) | -$3.05M(+28.5%) | -$9.26M(-18.0%) |
| Sep 2001 | - | -$2.37M(+41.0%) | -$11.29M(-8.2%) |
| Jun 2001 | - | -$1.68M(-21.9%) | -$12.29M(-8.5%) |
| Mar 2001 | - | -$2.15M(-57.7%) | -$13.44M(+5.5%) |
| Dec 2000 | -$12.74M(+177.0%) | -$5.08M(+50.6%) | -$12.74M(+45.5%) |
| Sep 2000 | - | -$3.38M(+19.4%) | -$8.76M(+21.9%) |
| Jun 2000 | - | -$2.83M(+94.3%) | -$7.18M(+39.3%) |
| Mar 2000 | - | -$1.46M(+32.3%) | -$5.16M(+12.1%) |
| Dec 1999 | -$4.60M(-11.5%) | -$1.10M(-38.9%) | -$4.60M(-11.5%) |
| Sep 1999 | - | -$1.80M(+125.0%) | -$5.20M(+10.6%) |
| Jun 1999 | - | -$800.00K(-11.1%) | -$4.70M(-9.6%) |
| Mar 1999 | - | -$900.00K(-47.1%) | -$5.20M(0.0%) |
| Dec 1998 | -$5.20M(+8.3%) | -$1.70M(+30.8%) | -$5.20M(+13.0%) |
| Sep 1998 | - | -$1.30M(0.0%) | -$4.60M(+2.2%) |
| Jun 1998 | - | -$1.30M(+44.4%) | -$4.50M(0.0%) |
| Mar 1998 | - | -$900.00K(-18.2%) | -$4.50M(-4.3%) |
| Dec 1997 | -$4.80M(-12.7%) | -$1.10M(-8.3%) | -$4.70M(-13.0%) |
| Sep 1997 | - | -$1.20M(-7.7%) | -$5.40M(+3.8%) |
| Jun 1997 | - | -$1.30M(+18.2%) | -$5.20M(0.0%) |
| Mar 1997 | - | -$1.10M(-38.9%) | -$5.20M(0.0%) |
| Dec 1996 | -$5.50M | -$1.80M(+80.0%) | -$5.20M(+52.9%) |
| Sep 1996 | - | -$1.00M(-23.1%) | -$3.40M(+41.7%) |
| Jun 1996 | - | -$1.30M(+18.2%) | -$2.40M(+118.2%) |
| Mar 1996 | - | -$1.10M | -$1.10M |
FAQ
- What is Novavax annual earnings before interest & taxes?
- What is the all time high annual EBIT for Novavax?
- What is Novavax annual EBIT year-on-year change?
- What is Novavax quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Novavax?
- What is Novavax quarterly EBIT year-on-year change?
- What is Novavax TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Novavax?
- What is Novavax TTM EBIT year-on-year change?
What is Novavax annual earnings before interest & taxes?
The current annual EBIT of NVAX is -$156.54M
What is the all time high annual EBIT for Novavax?
Novavax all-time high annual earnings before interest & taxes is -$4.32M
What is Novavax annual EBIT year-on-year change?
Over the past year, NVAX annual earnings before interest & taxes has changed by +$372.07M (+70.39%)
What is Novavax quarterly earnings before interest & taxes?
The current quarterly EBIT of NVAX is $525.57M
What is the all time high quarterly EBIT for Novavax?
Novavax all-time high quarterly earnings before interest & taxes is $525.57M
What is Novavax quarterly EBIT year-on-year change?
Over the past year, NVAX quarterly earnings before interest & taxes has changed by +$666.75M (+472.28%)
What is Novavax TTM earnings before interest & taxes?
The current TTM EBIT of NVAX is $510.21M
What is the all time high TTM EBIT for Novavax?
Novavax all-time high TTM earnings before interest & taxes is $510.21M
What is Novavax TTM EBIT year-on-year change?
Over the past year, NVAX TTM earnings before interest & taxes has changed by +$891.59M (+233.78%)